Introduction
creatinine 481 mmol/l (elevated from 140 mmol/l at 24 weeks gestation). Coagulation screens were normal. Hypercalcaemia is a biochemical abnormality fre-Urine microscopy revealed occasional granular and quently encountered in clinical practice. Laboratory hyaline casts. Arterial blood gases revealed that the and radiological investigations appropriate to the clin-patient was profoundly alkalotic (pH 7.54, HCO 3 ical setting can usually determine the cause of this 40 mmol/l ), despite being uraemic, which correlated abnormality. Hypercalcaemia in the setting of acute with the history of prolonged vomiting. A renal ultrarenal failure (ARF ) is not uncommon but is typically sound revealed echogenic but normal sized kidneys. A associated with rhabdomyolysis [1] and resolves spon-presumptive diagnosis of pre-eclampsia was made. The taneously as renal function recovers. We report the patient underwent an emergency caesarean section and case of a patient who developed hypercalcaemia several was delivered of a healthy baby girl. On the following weeks after recovering from an episode of ARF. day the patient was transferred to our renal unit for Despite extensive investigations, we were unable to further management. find a cause for the patient's hypercalcaemia. A renal
The patient was stabilized and anti-hypertensive biopsy performed to investigate persistent mild renal therapy was introduced. Renal function improved dysfunction finally revealed the reason for the patient's without the need for dialysis. One week later on renal impairment. We speculate that the renal lesion discharge from hospital the patient was normotensive was also the cause of the associated hypercalcaemia.
(BP 140/80 mmHg) with a serum creatinine of 186 mmol/l and a normal corrected serum calcium of 2.62 mmol/l (normal range 2.2-2.7 mmol/l ). The only Case prescribed medications on discharge were omeprazole 20 mg daily and nifedipine LA 30 mg daily. On review A 31-year-old female was admitted to a local maternity in the clinic 1 week later, serum creatinine had normalhospital in March 1998 at 35 weeks gestation com-ized to 118 mmol/l with a corrected serum calcium of plaining of severe nausea and vomiting that had 2.49 mmol/l. During the next 8 weeks, asymptomatic become marked in the 3 weeks prior to hospital hypercalcaemia developed and renal function deterioradmission. The patient was normotensive with a ated concomitantly ( Figure 1 ). Of note, dietary calnormal blood glucose and negative dipstick urinalysis cium intake was normal. Hypertension worsened throughout pregnancy. Severe iron deficiency anaemia necessitating the introduction of atenolol. Investiga-(haemoglobin 6.6 g/dl ) developed at 24 weeks gesta-tions performed 1 week after the onset of hypercalcaetion. There was no past medical or surgical history of mia revealed the following: serum calcium 3.22 mmol/l, note. Medications included ferrous sulphate and cal-serum creatinine 237 mmol/l, serum phosphate cium carbonate containing antacids (4-5 g daily). On 1.59 mmol/l, parathyroid hormone (PTH ) 18.7 pg/ml admission, the patient was hypertensive (blood pres-(range 10-65 pg/ml ) and 25-hydroxycholecalciferol sure (BP) 160/100 mmHg). Dipstick urinalysis revealed 9.9 ng/ml (range 6.7-52 ng/ml ) both of which were at the lower limit of normal. Serum angiotensin- IU/l ). Thyroid function tests, serum cortisol levels and tumour markers (CEA, aFP, CA125) were all within to be the patient's baseline. After 18 months of clinical follow-up, the patient remains normocalcaemic with normal limits. Immunological investigations including urine and serum protein electrophoresis were negative. no clinical evidence of granulomatous disease. Mild renal dysfunction persists. Radiological investigations including a chest radiograph and a parathyroid gland uptake scan were normal. An abdominal ultrasound revealed normal Discussion sized kidneys with decreased corticomedullary differentiation. No clear cause for either the hypercalcaemia or recurrence of renal impairment could be determined. The 31-year-old female patient in this study developed hypercalcaemia and persistent renal impairment folIn view of the patient's persistent renal dysfunction, a percutaneous renal biopsy was performed 5 weeks lowing resolution of pregnancy-related ARF. The renal biopsy findings, in particular the intense eosinophilic after the onset of hypercalcaemia. This revealed a diffuse mixed inflammatory infiltrate with several non-infiltrates and tubule-destructive granulomata, are most consistent with a drug-induced interstitial nephcaseating granulomata localized around damaged tubules. Lymphocytes were the predominant cell type, ritis. The main differential diagnosis in this case was renal sarcoidosis, which is characterized microscopicbut numerous clusters of eosinophils were also present throughout the biopsy. The granulomata differed from ally by granulomata. However, the intense eosinophilic infiltrate, clinical presentation and subsequent lack of those found in sarcoidosis and were typical of those encountered in a minority of cases of tubulointerstitial other organ involvement render this diagnosis unlikely.
Acute interstitial nephritis (AIN ) is identified in up nephritis. Histiocytes were immunoreactive for CD-68 and tubular epithelial cells stained positively for EMA to 15% of patients who undergo a renal biopsy for investigation of ARF [2] . Drug hypersensitivity is a and cytokeratin. Glomeruli were normal by light and immunofluoresence microscopy. Electron microscopy major cause of AIN with penicillins, cephalosporins and non-steroidal anti-inflammatory drugs (NSAIDs) revealed moderate foot process effacement. A presumptive diagnosis of drug-induced granulomatous being the most commonly implicated drugs [2] . At the time of renal biopsy, the patient was receiving nifedipinterstitial nephritis was made. At this point, the patient was receiving nifedipine LA 30 mg and atenolol ine LA and atenolol for hypertension. Omeprazole was discontinued by the patient 2 weeks prior to the renal 50 mg daily. The patient had discontinued omeprazole approximately 2 weeks prior to her renal biopsy. biopsy. Neither atenolol nor nifedipine are likely causal agents in this case. Atenolol was introduced following Prednisolone was commenced at a dose of 40 mg daily for 4 weeks and was subsequently tapered to stop by the onset of hypercalcaemia and renal impairment.
Nifedipine was continued after cessation of steroid 12 weeks. One week after the introduction of corticosteroids, the patient's serum calcium had normalized therapy with no recurrence of hypercalcaemia or renal impairment. We consider omeprazole to be the most and the serum creatinine was 200 mmol/l with a serum phosphate of 1.19 mmol/l (Figure 1) . Two weeks later likely cause of this patient's AIN even though the drug was discontinued 2 weeks prior to biopsy. the serum creatinine was 141 mmol/l, which we consider Omeprazole-induced AIN has been well documented A trial of corticosteroid therapy has been widely advocated in the acute management of hypercalcaemia. with 16 cases reported to date in the world literature of which 11 were biopsy-confirmed [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . A pre-In this particular case, such a trial may well have proved effective and the underlying renal pathology sumptive diagnosis of AIN was made in the five patients who had not had biopsies based on typical might never have been revealed. Finally, as omeprazole is a widely prescribed drug, clinicians should be aware clinical and laboratory findings together with recovery of renal function following withdrawal of omeprazole of its rare association with renal failure due to AIN. therapy [5, 7, 13, 14, 17] was present early in our patient and was initially Med J Aust 1996; 165: 234-235 ascribed to pre-eclampsia and possible mild pre- 
